Issued Patents All Time
Showing 1–25 of 41 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12240882 | Fusion proteins comprising an engineered knottin peptide and uses thereof | Douglas Jones, Mihalis Kariolis, Ping-Chuan Tsai | 2025-03-04 |
| 12049490 | Soluble leukemia inhibitory factor receptor polypeptides and methods of using same for inhibiting leukemia inhibitory factor activity | Sean Yamada-Hunter | 2024-07-30 |
| 12024705 | Methods and systems for screening using microcapillary arrays | Bob Chen, Spencer Alford | 2024-07-02 |
| 11498952 | Fusion proteins comprising an engineered knottin peptide and uses thereof | Douglas Jones, Mihalis Kariolis, Ping-Chuan Tsai | 2022-11-15 |
| 11473081 | Methods and systems for screening using microcapillary arrays | Bob Chen, Spencer Alford | 2022-10-18 |
| 11466063 | Conjugated knottin mini-proteins containing non-natural amino acids | Jun Woo Kim, Frank V. Cochran | 2022-10-11 |
| 11446356 | Peptides and related compositions and methods | Richard H. Kimura, Aron Levin | 2022-09-20 |
| 11208462 | Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same | Jun Woo Kim, Eric Alejandro Sweet | 2021-12-28 |
| 11179441 | Ciliary neurotrophic factor receptor ligands and methods of using the same | Jun Woo Kim, Eric Alejandro Sweet | 2021-11-23 |
| 11136563 | Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy | Amato J. Giaccia, Erinn Bruno Rankin, Douglas Jones, Mihalis Kariolis, Katherine Fuh +2 more | 2021-10-05 |
| 11096989 | Synergistic tumor treatment with an extended pharmacokinetic IL-2 and integrin-binding-Fc fusion protein | Karl Dane Wittrup, Byron Hua Kwan | 2021-08-24 |
| 11085039 | Methods and systems for screening using microcapillary arrays | Bob Chen, Spencer Alford | 2021-08-10 |
| 10888603 | Methods of treating cancer cells expressing tumor-associated integrins | Karl Dane Wittrup, Darrell J. Irvine, Cary Francis OPEL, Kelly Dare MOYNIHAN, Byron Hua Kwan | 2021-01-12 |
| 10844106 | Fusion proteins comprising an engineered knottin peptide and uses thereof | Douglas Jones, Mihalis Kariolis, Ping-Chuan Tsai | 2020-11-24 |
| 10765625 | Knottin-drug conjugates and methods of using the same | Nicholas Raymond Cox, Mark Smith, James R. KINTZING | 2020-09-08 |
| 10603358 | Combination tumor treatment with an integrin-binding-Fc fusion protein and immune stimulator | Karl Dane Wittrup | 2020-03-31 |
| 10526600 | Micro-screening apparatus, process, and products | Thomas M. Baer, Bob Chen, Spencer Alford, Ivan K. Dimov | 2020-01-07 |
| 10407477 | Conjugated knottin mini-proteins containing non-natural amino acids | Jun Woo Kim, Frank V. Cochran | 2019-09-10 |
| 10370653 | Micro-screening apparatus, process, and products | Thomas M. Baer, Bob Chen, Spencer Alford, Arvind Kannan, Sungwon Lim +1 more | 2019-08-06 |
| 10350266 | Method of treating cancer with a multiple integrin binding Fc fusion protein | Karl Dane Wittrup | 2019-07-16 |
| 10227583 | Methods and systems for screening using microcapillary arrays | Bob Chen, Spencer Alford | 2019-03-12 |
| 10166273 | Synergistic tumor treatment with antibodies targeting PD-1, PD-L1 or CTLA4 and integrin-binding-Fc-fusion protein | Karl Dane Wittrup, Byron Hua Kwan | 2019-01-01 |
| 9963495 | Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen | Cassie J. Liu | 2018-05-08 |
| 9913878 | Engineered integrin binding peptide compositions | Richard H. Kimura, Aron Levin | 2018-03-13 |
| 9879061 | Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis | Patrick O'Connor, Raymond Tabibiazar, Amato J. Giaccia, Erinn Bruno Rankin, Douglas Jones +3 more | 2018-01-30 |